Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Boger

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Biochemistry|October 17, 1989
X-ray studies of aspartic proteinase-statine inhibitor complexesJ B Cooper, S I Foundling, T L Blundell, et al.
Transplantation Proceedings|December 1, 1992
Pretransplant hypertension as the main determinant of postrenal transplant high blood pressureR C Manfro, F S Thomé, S C Schacher, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1985
Comparison of renin and converting enzyme inhibition in sodium-deficient dogsE H Blaine, B J Nelson, A A Seymour, et al.
Journal of Medicinal Chemistry|May 1, 1989
2,3-Dihydro-5-benzofuranols as antioxidant-based inhibitors of leukotriene biosynthesisM L Hammond, I E Kopka, R A Zambias, et al.
Regulatory Peptides. Supplement|January 1, 1985
Design of proteolytically-stable, peptidal renin inhibitors and determination of their fate in vivoJ Boger, C D Bennett, L S Payne, et al.
Journal of Healthcare Informatics Research|April 13, 2022
Comparative Analysis of Gait Speed Estimation Using Wideband and Narrowband Radars, Thermal Camera, and Motion Tracking Suit TechnologiesP P Morita, A S Rocha, G Shaker, et al.
Transplantation Proceedings|April 1, 1988
A study of the correlation between cyclophilin binding and in vitro immunosuppressive activity of cyclosporine A and analoguesP L Durette, J Boger, F Dumont, et al.
Anti-Cancer Drugs|February 1, 1997
Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitroU A Germann, D Shlyakhter, V S Mason, et al.
The Biochemical Journal|February 1, 1990
The selectivity of statine-based inhibitors against various human aspartic proteinasesR A Jupp, B M Dunn, J W Jacobs, et al.
Journal of Medicinal Chemistry|December 1, 1985
A uniquely potent renin inhibitor and its unanticipated plasma binding componentB E Evans, K E Rittle, M G Bock, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Biochemistry|October 17, 1989
X-ray studies of aspartic proteinase-statine inhibitor complexesJ B Cooper, S I Foundling, T L Blundell, et al.
Transplantation Proceedings|December 1, 1992
Pretransplant hypertension as the main determinant of postrenal transplant high blood pressureR C Manfro, F S Thomé, S C Schacher, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1985
Comparison of renin and converting enzyme inhibition in sodium-deficient dogsE H Blaine, B J Nelson, A A Seymour, et al.
Journal of Medicinal Chemistry|May 1, 1989
2,3-Dihydro-5-benzofuranols as antioxidant-based inhibitors of leukotriene biosynthesisM L Hammond, I E Kopka, R A Zambias, et al.
Regulatory Peptides. Supplement|January 1, 1985
Design of proteolytically-stable, peptidal renin inhibitors and determination of their fate in vivoJ Boger, C D Bennett, L S Payne, et al.
Journal of Healthcare Informatics Research|April 13, 2022
Comparative Analysis of Gait Speed Estimation Using Wideband and Narrowband Radars, Thermal Camera, and Motion Tracking Suit TechnologiesP P Morita, A S Rocha, G Shaker, et al.
Transplantation Proceedings|April 1, 1988
A study of the correlation between cyclophilin binding and in vitro immunosuppressive activity of cyclosporine A and analoguesP L Durette, J Boger, F Dumont, et al.
Anti-Cancer Drugs|February 1, 1997
Cellular and biochemical characterization of VX-710 as a chemosensitizer: reversal of P-glycoprotein-mediated multidrug resistance in vitroU A Germann, D Shlyakhter, V S Mason, et al.
The Biochemical Journal|February 1, 1990
The selectivity of statine-based inhibitors against various human aspartic proteinasesR A Jupp, B M Dunn, J W Jacobs, et al.
Journal of Medicinal Chemistry|December 1, 1985
A uniquely potent renin inhibitor and its unanticipated plasma binding componentB E Evans, K E Rittle, M G Bock, et al.
Pageof 4